Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2026-01-09 @ 7:44 PM
Study NCT ID:
NCT02181361
Status:
COMPLETED
Last Update Posted:
2020-04-21
First Post:
2014-06-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
Sponsor:
Xijing Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Xijing-4-3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |